Additionally, this group exhibited increased comorbidities such as hypertension (p = 0.005), diabetes mellitus (p = 0.016), coronary artery disease (p = 0.009), D-Dimer (p = 0.019), PCT (p < 0.0001), LDH (p < 0.0001), and CRP (p < 0.0001) levels, along with reduced levels of lymphocytes (p < 0.0001) and ALB (p = 0.018). This evidence concerns the gene CRP and diabetes mellitus.